180 related articles for article (PubMed ID: 18348457)
1. Melanoma and nonmelanoma skin cancers and the immune system.
Domingo DS; Baron ED
Adv Exp Med Biol; 2008; 624():187-202. PubMed ID: 18348457
[No Abstract] [Full Text] [Related]
2. Basal cell carcinoma, squamous cell carcinoma and melanoma of the head and face.
Feller L; Khammissa RAG; Kramer B; Altini M; Lemmer J
Head Face Med; 2016 Feb; 12():11. PubMed ID: 26850723
[TBL] [Abstract][Full Text] [Related]
3. Immune response to basal cell and squamous cell carcinomas.
Grimwood RE
Immunol Ser; 1989; 46():789-98. PubMed ID: 2488879
[TBL] [Abstract][Full Text] [Related]
4. Skin cancer treatment options: new horizons and promises for the future.
Semkova K; Tchernev G; Wollina U
Wien Med Wochenschr; 2013 Aug; 163(15-16):345-6. PubMed ID: 23846703
[No Abstract] [Full Text] [Related]
5. [Initial success with topical immunomodulators. A creme for skin cancer? (interview by Renate Jackle)].
Hengge U
MMW Fortschr Med; 2001 May; 143(21):11. PubMed ID: 11420824
[No Abstract] [Full Text] [Related]
6. Immune response associated with nonmelanoma skin cancer.
Strickland FM; Kripke ML
Clin Plast Surg; 1997 Oct; 24(4):637-47. PubMed ID: 9342507
[TBL] [Abstract][Full Text] [Related]
7. DNCB reactivity in patients with skin carcinoma.
Bleumink E; Nater JP
Dermatologica; 1974; 148(1):44-6. PubMed ID: 4364858
[No Abstract] [Full Text] [Related]
8. The immune system and skin cancer.
Yu SH; Bordeaux JS; Baron ED
Adv Exp Med Biol; 2014; 810():182-91. PubMed ID: 25207366
[TBL] [Abstract][Full Text] [Related]
9. T lymphocytes with Fc-IgG receptors in skin cancers.
Vena GA; Angelini G; D'Ovidio R; Lospalluti M; Meneghini CL
Acta Derm Venereol; 1981; 61(6):555-8. PubMed ID: 6177170
[No Abstract] [Full Text] [Related]
10. The immunology of basal cell carcinoma.
Myskowski PL; Safai B
Int J Dermatol; 1988 Nov; 27(9):601-7. PubMed ID: 3068167
[No Abstract] [Full Text] [Related]
11. Melanoma and nonmelanoma skin cancer.
Curr Opin Oncol; 1991 Apr; 3(2):420-32. PubMed ID: 2070001
[No Abstract] [Full Text] [Related]
12. Immune regulation by polysaccharides: implications for skin cancer.
Strickland FM
J Photochem Photobiol B; 2001 Oct; 63(1-3):132-40. PubMed ID: 11684460
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to basal epidermal cells in patients with basal or squamous cell carcinoma.
Ackermann-Schopf CM
Arch Dermatol Res (1975); 1976 Dec; 257(2):149-56. PubMed ID: 1008612
[TBL] [Abstract][Full Text] [Related]
14. Quantitative immunocytochemical study of plasma cells in skin tumoral stromal reaction.
Bustamante R; Faure M; Bejui F; Thivolet J
Eur J Cancer (1965); 1978 Oct; 14(10):1043-50. PubMed ID: 568551
[No Abstract] [Full Text] [Related]
15. Immune response modifiers and cutaneous neoplasia.
Spencer JM
Postgrad Med; 2002 Dec; 112(6 Suppl Using):17-21. PubMed ID: 19667609
[TBL] [Abstract][Full Text] [Related]
16. HLA and skin cancer.
Bonamigo RR; Carvalho AV; Sebastiani VR; Silva CM; Pinto AC
An Bras Dermatol; 2012; 87(1):9-16; quiz 17-8. PubMed ID: 22481646
[TBL] [Abstract][Full Text] [Related]
17. Cancer topics: immunology and cancer revisited.
O'Brien PH
J S C Med Assoc; 1974 Jul; 70(7):223-6. PubMed ID: 4603086
[No Abstract] [Full Text] [Related]
18. Th17 cytokines in non-melanoma skin cancer.
McAllister F; Kolls JK
Eur J Immunol; 2015 Mar; 45(3):692-4. PubMed ID: 25655439
[TBL] [Abstract][Full Text] [Related]
19. Risk of skin cancer in people with vitiligo: a systematic review and meta-analysis.
Ban L; Labbouz S; Grindlay D; Batchelor JM; Ratib S
Br J Dermatol; 2018 Oct; 179(4):971-972. PubMed ID: 29704869
[No Abstract] [Full Text] [Related]
20. A comparative study of a number of nutritional and immunological indices in patients with skin carcinoma.
Moriarty M; O'Loughlin G; McFarlane R; Johnson A; Collins P; Mulgrew S; Conroy R; Daly L
Ir J Med Sci; 1983 Jun; 152(6):242-5. PubMed ID: 6874293
[No Abstract] [Full Text] [Related]
[Next] [New Search]
